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HIV-1 Tat expression will interact with aging as assessed
by affective, antinociceptive, and neuromuscular




HIV-1 Tat or Aging Influences Neuromuscular Function
Aging Potentiates Mechanical Allodynia
Neither Tat nor Aging Produce Thermal Hyperalgesia
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v Combination antiretroviral therapy (cART) has significantly
reduced the incidence of HIV-1 associated dementia and increased
life expectancy among infected patients. However, ~50% of the
HIV+ population still suffers from neurological and psychological
symptoms, including increased incidence of cognitive deficits,
anxiety/depression, and neuropathic pain, collectively called
neuroHIV [1,3].
v HIV-1 proteins, such as the trans-activator of transcription (Tat),
are neurotoxic, remain present in the central nervous system
despite combined antiretroviral therapy, and are thought to
contribute to neuroHIV [2, 4].
v The U.S. HIV+ population is aging with over 60% of individuals
45 years or older. These individuals experience accelerated aging
and characterized by vulnerability to numerous age-related
comorbidities, including endocrine and immune dysfunction,
neurocognitive deficits, vascular and metabolic disorders [4-6].
v HIV-1 Tat protein, cART, and chronological aging can disrupt
endocrine function, dysregulate the hypothalamic-pituitary-
adrenal and -gonadal axes, and impair steroidogenesis. [4-7].
Animal Housing
HIV-1 Tat transgenic mice were generated in the vivarium at the University of
Mississippi (University, MS). HIV-1 Tat1-86 protein is expressed via a glial fibrillary
acidic protein (GFAP)-driven, tetracycline (Tet)-on promoter activated by doxycycline
(30 mg/kg, i.p.). Middle-aged (6-8 mons) and Aged (11-13 mos), male (n=43) that
expressed Tat (Tat+) and their non-Tat-expressing counterparts (Tat-) were housed (4-
5/cage) in a temperature- and humidity-controlled room on a reversed 12:12 h
light/dark cycle (lights off at 20:00 h).
Elevated Plus Maze (EPM)
Mice were placed in the center of an elevated plus maxe (5× 5 cm) and allowed to
explore the maze for 5 min. Animals were tracked digitally using Noldus Ethovision
tracking software. The latency to enter, and time spent on, the open arms of the maze
were considered an index of anti-anxiety-like behavior.
Grip Strength
The apparatus consisted of a wire bar grid connected to a force transducer that recorded
the maximal force (g) created by gently pulling mice from the bar by the base of the tail
until the grip was released. Grip strength was assessed independently for the forelimbs
vs. all four limbs.
Electronic Von Frey (eVF) Mechanical Allodynia
The eVF probe was applied to the middle plantar surface of the hind paw and force was
incrementally increased until paw withdrawal. The required force (g) to produce the
withdrawal was recorded. Each mouse was tested in eight trials (4: right and 4: left)
alternating between right and left paws with a 3-min interval break between trials.
Thermal Hyperalgesia
A radiant heat source was applied to the middle plantar surface of the hind paw
(2.5 ̊C/sec) until paw withdrawal. Each mouse underwent 4 trials (2: right and 2: left)
with a 3 -5 min interval break between trials.
Figure 1: (A) Tat exposure and aging increased anxiety-like behavior. (D) Aged Tat + male showed a lower % open arm entries. * indicates Tat+
significantly differs from respective Tat- control group. ^ indicates aged male significantly differs from respective middle-aged group. ‡ indicates
significant difference from all other groups (2-way ANOVA, p < 0.05).
Figure 2: (A) Irrespective of Tat exposure, aged mice demonstrated increased  mechanical allodynia. (B) Neither Tat nor aging influenced thermal 
hyperalgesia. † indicates Tat- control group significantly differs from all other groups  (2-way ANOVA , p < 0.05).
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Thus, HIV-1 Tat promoted anxiety–like behavior, allodynia, and
neuromuscular dysfunction among aged mice. For neuromuscular
function in particular, Tat expression accelerated age-related deficits.
Future studies will determine whether administration of exogenous
steroid hormones can ameliorate Tat- and age-related comorbidities.
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vHIV-1 Tat expression or aging increased anxiety-like behavior in the
elevated plus maze (Fig. 1A-B)
vAging increased mechanical allodynia with no effect on thermal
hyperalgesia (Fig. 2A-B).
vAging reduced neuromuscular function when assessed either by
forepaws alone or all four limbs together (forepaws + hindpaws)
(Fig.3A-B).
vTat exposure and aging altered heart and spleen weight (Fig.4B-C).
Conclusion
HIV-1 Tat or Aging Alters Organ Weight 
(Proportional to Body Weight)
Figure 3: Tat exposure or aging influenced muscle strength normalized to body weight (A) in forelimbs (B) in all four limbs exposure. † indicates
Tat- control group significantly differs from all other groups . ^ indicates significant difference from aged Tat – group (2-way ANOVA, p < 0.05).
Figure 4: (A) Neither Tat or aging altered brain weight.(B) Tat exposure and aging influenced heart weight .(C) Tat+ aged mice
had a heavier spleen .(D) Neither Tat or aging altered liver weight. All body organs were normalized to body weight. ^ indicates
Tat+ middle-aged male significantly differs from Tat- middle-aged and Tat+ Aged mice. § indicates significant difference from
all other groups. (2-way ANOVA, p < 0.05).
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